Golembiewski Michael Joseph 4
4 · SEELOS THERAPEUTICS, INC. · Filed Jan 11, 2022
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-10+500,000→ 500,000 totalExercise: $1.46Exp: 2032-01-10→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on January 10, 2023, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.